Edit search
Systemic treatment of psoriatic patients with bexarotene dec…
Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation%2C and improves differentiation in lesional skin.
Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation%2C and improves differentiation in lesional skin.
Article, Chapter
Authors: J.V.
Publication: Volume:51, Issue:2, Page(s):257-264
Published: 2004
Browse related articles
  Request a copy of this item
Cite this item